To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open2,355
High2,399.3
Low2,338.3
Prev. Close2,358.5
Avg. Traded Price2,372.78
Volume18,498

MARKET DEPTH

info2
Total bid14,091.00
Total ask27,711.00
OrdersQtyBid
1252380
112379.6
182379.5
112379.4
132379.1
AskQtyOrders
2381.911
2382.311
2382.4113
2382.527
2382.624

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

2,338.3029 minutes ago
2,399.90a minute ago
arrow

LOWER/UPPER CIRCUITS

1,886.80
2,830.20
arrow
Shaily Engineering Plastics Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 21.34%, in the last year to ₹789.12 Cr. Its sector's average revenue growth for the last fiscal year was 12.23%.
noteAnnual Net Profit,rose 62.54% in the last year to ₹93.12 Cr. Its sector's average net profit growth for the last fiscal year was 13.31%.
noteQuarterly Revenue,rose 37.52% YoY to ₹248.78 Cr. Its sector's average revenue growth YoY for the quarter was 7.66%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : 24.33%
Shaily Engineering Plastics Ltd Top mutual funds holding
arrow

About Shaily Engineering Plastics Limited

Shaily Engineering Plastics Limited is an India‑domiciled precision injection moulding company incorporated on April 18, 1980, manufacturing high‑precision plastic components and moulds for healthcare, consumer, industrial, automotive, appliances, electronics, and LED lighting customers on a contract basis and through IP‑led devices in drug delivery and pharma packaging. It operates 6 plants and 3 offices in India with international commercial presence via subsidiaries, serving customers across 15 Indian States and 35 countries, with exports contributing 77.9% of FY 2024‑25 turnover. The Company’s wholly owned subsidiaries are Shaily Innovations Limited (formerly Shaily UK Limited) and Shaily Innovations FZCO, Dubai, UAE, each held 100% and not participating in the parent’s BRSR initiatives; corporate and registered offices are at Survey No. 364/366, Rania, Taluka Savli, Dist. Vadodara, Gujarat 391780. Key milestones in FY 2024‑25 include expanding healthcare manufacturing, developing an auto‑injector and multiple pen devices, completing in‑house moulding for Gillette and GE, installing an automated UV coating line, and developing premium EV components with global partners.

Shaily Engineering Plastics Limited Business Segment

  • Reportable segments: Management reports the Company as a single operating segment under Ind AS 108, aggregating contract manufacturing activities across industries due to similar economic characteristics; hence, segment revenue/asset disclosures follow financial statements.

  • Revenue by geography (consolidated): India Rs 161.64 crore; Outside India Rs 620.69 crore; Total Rs 781.23 crore for the year ended March 31, 2025, based on “H in Lakhs” unit header converted to crore as per instructions.

  • Customer concentration: One major customer contributed Rs 505.97 crore (H 50,596.54 lakh) of revenue in FY 2024‑25.

  • Disaggregation (prior year reference within notes): Consumer, Industrial, and Pharma were disclosed for FY 2023‑24; current year remains a single operating segment with disaggregation objective met through Note 32.

Geographic split (consolidated)

  • India — Rs 161.64 crore (20.7%)

  • International — Rs 620.69 crore (79.3%)

Shaily Engineering Plastics Limited Key Management

  • Mahendra Sanghvi — Executive Chairman

  • Amit Sanghvi — Managing Director

  • Laxman Sanghvi — Executive Director

  • Tilottama Sanghvi — Whole Time Director

  • Paresh Jain — Chief Financial Officer (joined April 11, 2024)

  • Harish Punwani — Company Secretary (joined November 21, 2024)

Latest Updates on Shaily Engineering Plastics Limited

  • Expanded healthcare manufacturing capacity to meet rising injectable drug delivery demand, especially GLP‑1 therapies.

  • Developed a three‑step and a two‑step auto‑injector for GLP‑1 class, plus multiple pen platforms including ShailyPen Neo, Protean, Axiom, and Maxim; signed two new customers for IP‑led pen platforms and secured eight contracts for pens/auto‑injectors.

  • Planned pharma capex of approximately H 150 crore within an estimated H 185 crore annual capex to add 40–50 million pens per year; pharma gross block expected around H 375 crore post investments, with overall gross block rise of ~H 170 crore by year‑end.

  • Completed in‑house moulding for Gillette and General Electric; installed a new automated UV coating line; developed premium EV components with global leaders.

Strengthened presence in regulated markets through participation at Pharmapack, CPHI, PDA, and PODD; exports accounted for 77.9% of turnover in FY 2024‑25.

personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

The Company serves 15 Indian States and 35 countries; exports were 77.9% of FY 2024‑25 turnover.

Two wholly owned subsidiaries: Shaily Innovations Limited and Shaily Innovations FZCO, Dubai, UAE.

No, it reports a single operating segment under Ind AS 108, aggregating contract manufacturing across industries.